» Articles » PMID: 19268907

Outcome After Curative Resection for a Huge (>or=10 Cm) Hepatocellular Carcinoma and Prognostic Significance of Gross Tumor Classification

Overview
Journal Am J Surg
Specialty General Surgery
Date 2009 Mar 10
PMID 19268907
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The purpose of this study was to investigate the surgical outcomes in patients with huge (>or=10 cm) hepatocellular carcinoma (HCC).

Methods: Clinicopathological features and surgical outcomes of 50 patients with huge HCC who underwent curative resection (group A) were compared with 447 patients with smaller tumors (group B). In group A, we investigated prognostic factors.

Results: Group A patients had a higher incidence of alpha-fetoprotein at more than 1,000 IU/mL, microscopic vascular invasion, and advanced stage tumors. The disease-free survival of group A was significantly worse than group B. The rates of initial extrahepatic recurrence and early recurrence were higher in group A. The 5 year-overall survival of group A was 40.2%, significantly lower than that of group B (65.9% at 5 years). In group A, multivariate analysis revealed that the presence of single nodular type tumors was the only good prognostic factor for survival.

Conclusions: Huge HCCs exhibit a more aggressive clinical behavior and worse survival. However, because the outcome of surgical treatment is far better than that of nonsurgical treatment, resection should be actively considered for patients with huge HCC. A single nodular type tumor is the best candidate for surgical resection.

Citing Articles

Preoperative predictors of very early recurrence in patients with hepatocellular carcinoma beyond the Milan criteria.

Yasuda S, Matsuo Y, Doi S, Sakata T, Nagai M, Nakamura K Langenbecks Arch Surg. 2024; 409(1):283.

PMID: 39292284 DOI: 10.1007/s00423-024-03474-x.


Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study.

Gao Y, Xu Y, Wang Y, Lu J, Guo J J Gastrointest Oncol. 2024; 15(3):1122-1140.

PMID: 38989427 PMC: 11231877. DOI: 10.21037/jgo-24-298.


Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors.

Gonvers S, Martins-Filho S, Hirayama A, Calderaro J, Phillips R, Uldry E J Hepatocell Carcinoma. 2024; 11:707-719.

PMID: 38605975 PMC: 11007400. DOI: 10.2147/JHC.S447848.


Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma-a multicenter propensity score matching analysis.

Xu X, Wu H, Li J, Yao L, Huang B, Diao Y Hepatobiliary Surg Nutr. 2023; 12(3):314-327.

PMID: 37351131 PMC: 10282672. DOI: 10.21037/hbsn-21-423.


Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm.

Pandrowala S, Patkar S, Goel M, Mirza D, Mathur S Langenbecks Arch Surg. 2023; 408(1):144.

PMID: 37041364 DOI: 10.1007/s00423-023-02881-w.